{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1361418520936622720.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.4155/fmc.15.144"}},{"identifier":{"@type":"URI","@value":"https://www.tandfonline.com/doi/pdf/10.4155/fmc.15.144"}}],"dc:title":[{"@value":"Oligonucleotide Therapeutics: Chemistry, Delivery and Clinical Progress"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1381418520936622720","@type":"Researcher","foaf:name":[{"@value":"Vivek K Sharma"}],"jpcoar:affiliationName":[{"@value":"Department of Chemistry & Institute for Life Sciences, University of Southampton, Highfield, Southampton, SO17 1BJ, UK"},{"@value":"RNA Therapeutics Institute & Department of Biochemistry & Molecular Pharmacology, University of Massachusetts Medical School, Worcester, MA01605, USA"}]},{"@id":"https://cir.nii.ac.jp/crid/1381418520936622721","@type":"Researcher","foaf:name":[{"@value":"Jonathan K Watts"}],"jpcoar:affiliationName":[{"@value":"Department of Chemistry & Institute for Life Sciences, University of Southampton, Highfield, Southampton, SO17 1BJ, UK"},{"@value":"RNA Therapeutics Institute & Department of Biochemistry & Molecular Pharmacology, University of Massachusetts Medical School, Worcester, MA01605, USA"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"17568919"},{"@type":"EISSN","@value":"17568927"}],"prism:publicationName":[{"@value":"Future Medicinal Chemistry"}],"dc:publisher":[{"@value":"Informa UK Limited"}],"prism:publicationDate":"2015-10","prism:volume":"7","prism:number":"16","prism:startingPage":"2221","prism:endingPage":"2242"},"reviewed":"false","url":[{"@id":"https://www.tandfonline.com/doi/pdf/10.4155/fmc.15.144"}],"createdAt":"2015-10-29","modifiedAt":"2025-05-31","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360572092437230464","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"In vitro evolution of phi29 DNA polymerases through compartmentalized gene expression and rolling-circle replication"}]},{"@id":"https://cir.nii.ac.jp/crid/1360853567635854976","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Enhancements in the utilization of antigene oligonucleotides in the nucleus by booster oligonucleotides"}]},{"@id":"https://cir.nii.ac.jp/crid/2051151842048028672","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Chemically caged nucleic acids"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.4155/fmc.15.144"},{"@type":"CROSSREF","@value":"10.1093/protein/gzaa011_references_DOI_HuPsZNc2lzYL82fnymhDesE87Qg"},{"@type":"CROSSREF","@value":"10.1246/cl.161063_references_DOI_HuPsZNc2lzYL82fnymhDesE87Qg"},{"@type":"CROSSREF","@value":"10.1039/d0cc04240d_references_DOI_HuPsZNc2lzYL82fnymhDesE87Qg"}]}